Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia

NCT00509600 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Slow enrollment; study terminated.

Conditions

Leukemia

Interventions

DRUG: Etanercept

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]